Dror Ortho-Design

Dror Ortho-Design developed Aerodentis, a medical device that delivered low-amplitude, high-frequency vibrations through a removable mouthpiece. The device aimed to accelerate orthodontic tooth movement by stimulating alveolar bone remodeling. Patients used it for short daily sessions alongside existing braces or clear aligners.

No. In July 2019 the company acquired a controlling interest in an Israeli mobile-gaming studio and announced it was exiting the orthodontic business entirely. The public entity later became known as Nogin, Inc., an e-commerce platform, leaving the orthodontic assets non-operational.

Aerodentis received CE marking for sale in Europe. The company pursued FDA 510(k) clearance in the United States, a premarket notification pathway for Class II medical devices. Public filings do not indicate the FDA submission was completed before the 2019 pivot away from orthodontics.

Aerodentis applied cyclic mechanical loading — low-magnitude, high-frequency vibration — intended to accelerate the biological response to orthodontic force. The concept is that mechanical signals can upregulate bone-remodeling pathways, shortening the period teeth require to move through alveolar bone.

After exiting orthodontics in 2019, the public shell of Dror Ortho-Design was used for a reverse merger or business combination that resulted in the entity taking the name Nogin, Inc. Nogin operates as a commerce-as-a-service platform and bears no operational connection to the original orthodontic business or the Aerodentis product line.